Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

T20/DP178 And T21/DP107 Are Activators of Human Phagocyte Formyl Peptide Receptors

  • Read more about T20/DP178 And T21/DP107 Are Activators of Human Phagocyte Formyl Peptide Receptors
US Patent 6,830,893
Filed on 2001-11-02

A Kit For Determining DNA Double-Stranded Breaks With Anti-y-H2A Antibodies

  • Read more about A Kit For Determining DNA Double-Stranded Breaks With Anti-y-H2A Antibodies
US Patent 6,884,873
Filed on 2001-11-07

Extracellular cAMP-Dependent Protein Kinase in the Diagnosis and Prognosis And Treatment of Cancer

  • Read more about Extracellular cAMP-Dependent Protein Kinase in the Diagnosis and Prognosis And Treatment of Cancer
US Application 10/018,396
Filed on 2002-03-20

Geldanamycin Derivatives having Selective Affinity For HSP90 Over GRP94 and Method of Using Same

  • Read more about Geldanamycin Derivatives having Selective Affinity For HSP90 Over GRP94 and Method of Using Same
Patent Cooperation Treaty
PCT/US01/44172
Filed on 2001-11-06

RETROVIRUS VECTORS DERIVED FROM AVIAN SARCOMALEUKOSIS VIRUSES PERMITTING TRANSFER OF GENES INTO MAMMALIAN CELLS AND THERAPEUTIC USES THEREOF...

  • Read more about RETROVIRUS VECTORS DERIVED FROM AVIAN SARCOMALEUKOSIS VIRUSES PERMITTING TRANSFER OF GENES INTO MAMMALIAN CELLS AND THERAPEUTIC USES THEREOF...
US Patent 6,794,188
Filed on 2001-09-24

Chromosome 3p21.3 Genes Are Tumor Suppressors

  • Read more about Chromosome 3p21.3 Genes Are Tumor Suppressors
US Application 09/902,003
Filed on 2001-07-10

Thiazepine Inhibitors of HIV-1 Integrase

  • Read more about Thiazepine Inhibitors of HIV-1 Integrase
US Patent 7,015,212
Filed on 2001-11-09

Enchanced Efficacy and Safety of Genotoxic Therapy By P38 MAPK Modulation

  • Read more about Enchanced Efficacy and Safety of Genotoxic Therapy By P38 MAPK Modulation
Patent Cooperation Treaty
PCT/US01/47669
Filed on 2001-11-06

Use Of Mx GTPase In The Prognosis And Treatment Of Cancer

  • Read more about Use Of Mx GTPase In The Prognosis And Treatment Of Cancer
US Application 10/492,396
Filed on 2004-04-12

Neutrophil Chemotactic Factor (As Amended) [IL-8;NCF;MDNCF]

  • Read more about Neutrophil Chemotactic Factor (As Amended) [IL-8;NCF;MDNCF]
US Patent 6,475,741
Filed on 2001-11-09

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1483
  • Page 1484
  • Page 1485
  • Page 1486
  • Page 1487
  • Page 1488
  • Page 1489
  • Page 1490
  • Page 1491
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health